Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank36
3Y CAGR-50.3%
5Y CAGR-18.0%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-50.3%/yr
vs -7.4%/yr prior
5Y CAGR
-18.0%/yr
Recent deceleration
Acceleration
-42.9pp
Decelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$9.52M-63.9%
2023$26.38M-33.3%
2022$39.57M-49.0%
2021$77.55M+47.7%
2020$52.51M+104.2%
2019$25.71M-61.6%
2018$66.89M-36.5%
2017$105.40M+3.0%
2016$102.32M-38.9%
2015$167.59M-